Gene Panel Market: Global Industry Trends, Growth Opportunities, and Forecast
The Gene Panel Market is experiencing strong growth as healthcare systems increasingly adopt targeted genomic sequencing for cancer diagnosis, hereditary disease screening, pharmacogenetics, and precision medicine.
According to Market Research Future, the global market was valued at USD 3.56 billion in 2025 and is projected to increase from USD 4.12 billion in 2026 to USD 14.03 billion by 2035, registering a CAGR of 14.58% during 2026–2035.
The increasing adoption of next-generation sequencing is a major factor supporting market expansion. Gene panels enable laboratories and healthcare providers to analyze multiple genes simultaneously, making them valuable for oncology, hereditary disease assessment, and personalized treatment decisions.
Cancer risk assessment represented the largest application segment in 2025, while hospitals and clinics accounted for the largest end-user share. Test kits also dominated the product and services segment.
North America held the largest regional share in 2025, while Asia-Pacific is expected to record the fastest growth through 2035. Government genomics initiatives, expanding laboratory infrastructure, and increasing demand for precision medicine are contributing to regional expansion.
Overall, technological advances, improved reimbursement, falling sequencing costs, and increasing clinical adoption are expected to support continued growth of the global gene panel industry.